The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Good cop, bad cop: the different faces of NF-κB
Open accessAbstract
Complexes formed from the nuclear factor kappaB (NF-kappaB) family of transcription factors are ubiquitously expressed and are induced by a diverse array of stimuli. This results in their becoming activated in a wide variety of different settings. While the functions of NF-kappaB in many of these contexts have been the subject of intense research and are now well established, it is also clear that there is great diversity in the effects and consequences of NF-kappaB activation. NF-kappaB subunits do not necessarily regulate the same genes, in an identical manner, in all of the different circumstances in which they are induced. This review will discuss the different functions of NF-kappaB, the pathways that modulate NF-kappaB subunit activity and, in contrast to its more commonly thought of role as a promoter of cancer cell growth and survival, the ability of NF-kappaB, under some circumstances, to behave as a tumor suppressor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the NF-κB system (e.g. [2020-2024]) (Fig 8), NF-κB is normally held inactive in the cytoplasm by binding to an inhibitor IκB (often IκBα). Pro-inflammatory cytokines such as TNF-α, LPS [2025-2030] and IL-1 [2031] act by binding to receptors at the cell surface and initiating signalling pathways that lead to the activation of a particular kinase, IκB kinase or IKK. This kinase phosphorylates the”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2024]
Citations
Cites
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
Hoffmann, A., Levchenko, A., Scott, M. L., & Baltimore, D. (2002) · Science · doi:10.1126/science.1071914 · Cited by 1,890
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M., Bours, V., & Chariot, A. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,516
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
Cited by
Sorted by citations
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,277
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Self-citationTargeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,957
Cellular Stress Responses: Cell Survival and Cell Death
Fulda, S., Gorman, A. M., Hori, O., & Samali, A. (2010) · International Journal of Cell Biology · doi:10.1155/2010/214074 · Cited by 1,590
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3204 · Cited by 860
Self-citationSignaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Regulation of hypoxia-inducible factor-1α by NF-κB
van Uden, P., Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20080476 · Cited by 729
Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential
Paine, A., Eiz‐Vesper, B., Blasczyk, R., & Immenschuh, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.014 · Cited by 705
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
Ramos, S. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700326 · Cited by 701
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674
Self-citationFulda, S. (2008) · International Journal of Cancer · doi:10.1002/ijc.24064 · Cited by 613
Salminen, A., Huuskonen, J., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.09.002 · Cited by 581
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Transcriptional profiling of the LPS induced NF-κB response in macrophages
Sharif, O., Bolshakov, V. N., Raines, S., Newham, P., & Perkins, N. D. (2007) · BMC Immunology · doi:10.1186/1471-2172-8-1 · Cited by 513
Self-citationFuller-Pace, F. V. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl460 · Cited by 426
Oxidative Stress, Plant Natural Antioxidants, and Obesity
Pérez-Torres, I., Castrejón-Téllez, V., Soto, M. E., Rubio-Ruiz, M. E., Manzano-Pech, L., & Guarner‐Lans, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041786 · Cited by 437
Current insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 415
Autophagy in cancer associated fibroblasts promotes tumor cell survival
Martinez‐Outschoorn, U., Trimmer, C., Zhao, L., Whitaker‐Menezes, D., Chiavarina, B., Zhou, J., Wang, C., Pavlides, S., Cantarin, M. P. M., Capozza, F., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12928 · Cited by 413
Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.
Zabolotny, J. M., Kim, Y.-B., Welsh, L. A., Kershaw, E. E., Neel, B. G., & Kahn, B. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800061200 · Cited by 404
Bubici, C., Papa, S., Dean, K., & Franzoso, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209936 · Cited by 399
NF ‐κB and HIF crosstalk in immune responses
D’Ignazio, L., Bandarra, D., & Rocha, S. (2015) · FEBS Journal · doi:10.1111/febs.13578 · Cited by 383
Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer
Waes, C. V. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2221 · Cited by 293
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Fang, Z., Meng, Q., Xu, J., Wang, W., Zhang, B., Liu, J., Liang, C., Hua, J., Zhao, Y., Yu, X., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12392 · Cited by 304
Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65
Lu, T., Jackson, M. W., Wang, B., Yang, M., Chance, M. R., Miyagi, M., Gudkov, A. V., & Stark, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912493107 · Cited by 286
Baldwin, A. S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01095.x · Cited by 287
Mitochondria and Reactive Oxygen Species: Physiology and Pathophysiology
Bolisetty, S., & Jaimes, E. A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14036306 · Cited by 287
The role of Nuclear Factor-kappa B signaling in human cervical cancer
Tilborghs, S., Corthouts, J., Verhoeven, Y., Ron, D. A., Rolfo, C. D., Trinh, X. B., & van Dam, P. A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.11.001 · Cited by 279
Regulation of gene expression by hypoxia
Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20081055 · Cited by 269
IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κB
Schmid, J. A., & Birbach, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.006 · Cited by 263
Telomerase: central regulator of all of the hallmarks of cancer
Low, K. C., & Tergaonkar, V. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.07.001 · Cited by 265
NF-κB signaling is key in the wound healing processes of silk fibroin
Park, Y. R., Sultan, M. T., Park, H.-J., Lee, J. M., Ju, H. W., Lee, O. J., Lee, D. J., Kaplan, D. L., & Park, C. H. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.12.006 · Cited by 261
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
Gañán-Gómez, I., Wei, Y., Starczynowski, D. T., Colla, S., Yang, H., Cabrero-Calvo, M., Bohannan, Z. S., Verma, A., Steidl, U., & Garcia-Manero, G. (2015) · Leukemia · doi:10.1038/leu.2015.69 · Cited by 236
Mechanism of Hypoxia-Induced NF-κB
Culver, C. A., Sundqvist, A., Mudie, S., Melvin, A., Xirodimas, D. P., & Rocha, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00409-10 · Cited by 235
Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Ranjbar, A., Saleh, S. H. S., Bagherian, M., Sharifzadeh, S. O., Hushmandi, K., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.025 · Cited by 214
Caffeine effects on systemic metabolism, oxidative-inflammatory pathways, and exercise performance
Barcelos, R. P., Lima, F. D., de Carvalho, N. R., Bresciani, G., & Royes, L. F. F. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.05.005 · Cited by 248
Small Molecule NF-κB Pathway Inhibitors in Clinic
Ramadass, V., Vaiyapuri, T., & Tergaonkar, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145164 · Cited by 214
Evasion of Apoptosis as a Cellular Stress Response in Cancer
Fulda, S. (2010) · International Journal of Cell Biology · doi:10.1155/2010/370835 · Cited by 223
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z. J., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 209
Fetoni, A. R., Paciello, F., Rolesi, R., Paludetti, G., & Troiani, D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.022 · Cited by 210
Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately Linked
Wisastra, R., & Dekker, F. J. (2014) · Cancers · doi:10.3390/cancers6031500 · Cited by 209
Puar, Y., Shanmugam, M. K., Fan, L., Arfuso, F., Sethi, G., & Tergaonkar, V. (2018) · Biomedicines · doi:10.3390/biomedicines6030082 · Cited by 200
Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis
Bassères, D. S., Ebbs, A., Levantini, E., & Baldwin, A. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4290 · Cited by 189
The complex interplay between autophagy and NF-κB signaling pathways in cancer cells.
Trocoli, A., & Djavaheri‐Mergny, M. (2011) · PubMed · Cited by 184
The role of hypoxia in inflammatory disease (Review)
Biddlestone, J., Bandarra, D., & Rocha, S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2079 · Cited by 183
Steinbrecher, K. A., Harmel-Laws, E., Sitcheran, R., & Baldwin, A. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2588 · Cited by 177
Evolutionary Conserved Regulation of HIF-1β by NF-κB
van Uden, P., Kenneth, N. S., Webster, R., Müller, H. A., Mudie, S., & Rocha, S. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001285 · Cited by 163
PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis
Wang, P., Qiu, W., Dudgeon, C., Liu, H., Huang, C., Zambetti, G. P., Yu, J., & Zhang, L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.51 · Cited by 163
Interleukin‐10 provides direct trophic support to neurons
Zhou, Z., Peng, X., Insolera, R., Fink, D. J., & Mata, M. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06263.x · Cited by 156
D’Ignazio, L., & Rocha, S. (2016) · Cells · doi:10.3390/cells5010010 · Cited by 168
Yue, H., Brown, M., Knowles, J. D., Wang, H., Broomhead, D. S., & Kell, D. B. (2006) · Molecular BioSystems · doi:10.1039/b609442b · Cited by 146
Upregulation of Twist-1 by NF-κB Blocks Cytotoxicity Induced by Chemotherapeutic Drugs
Pham, C. G., Bubici, C., Zazzeroni, F., Knabb, J. R., Papa, S., Kuntzen, C., & Franzoso, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01219-06 · Cited by 144
Targeting apoptosis pathways in pancreatic cancer
Arlt, A., Müerköster, S. S., & Schäfer, H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.015 · Cited by 143
Guadagno, J., Xu, X., Karajgikar, M., Brown, A. M., & Cregan, S. P. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.59 · Cited by 146
Lee, S., Jeong, J.-J., Eun, S.-H., & Kim, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.011 · Cited by 141
Regulation of Programmed Cell Death by NF-κB and its Role in Tumorigenesis and Therapy
Fan, Y., Dutta, J., Gupta, N., Fan, G., & Gélinas, C. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_11 · Cited by 137
Haydar, D., Cory, T. J., Birket, S. E., Murphy, B. S., Pennypacker, K. R., Sinai, A. P., & Feola, D. J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801228 · Cited by 136
Regulation of p53 tumour suppressor target gene expression by the p52 NF‐κB subunit
Schumm, K., Rocha, S., Caamaño, J., & Perkins, N. D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601343 · Cited by 135
Self-citationInhibitory kappa B kinases as targets for pharmacological regulation
Gamble, C., McIntosh, K., Scott, R., Ho, K. H., Plevin, R. J., & Paul, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01608.x · Cited by 134
Ionizing radiation-induced NF-κB activation requires PARP-1 function to confer radioresistance
Veuger, S. J., Hunter, J. E., & Durkacz, B. W. (2008) · Oncogene · doi:10.1038/onc.2008.439 · Cited by 134
RetractedNucleolar NF-κB/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin
Khandelwal, N., Simpson, J., Taylor, G., Rafique, S., Whitehouse, A., Hiscox, J. A., & Stark, L. A. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.79 · Cited by 132
HIF-1α restricts NF-κB dependent gene expression to control innate immunity signals
Bandarra, D., Biddlestone, J., Mudie, S., Müller, H. ‐. J., & Rocha, S. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.017285 · Cited by 132
Sommermann, T. G., O’Neill, K. E., Plas, D. R., & Cahir-McFarland, E. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1715 · Cited by 129
Gene regulation by melatonin linked to epigenetic phenomena
Korkmaz, A., Rosales‐Corral, S., & Reiter, R. J. (2012) · Gene · doi:10.1016/j.gene.2012.04.040 · Cited by 132
The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
Doyle, P. S., Zhou, Y. M., Hsieh, I., Greenbaum, D. C., McKerrow, J. H., & Engel, J. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002139 · Cited by 130
Targeting apoptosis pathways in cancer stem cells
Signore, M., Ricci‐Vitiani, L., & Maria, R. D. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.013 · Cited by 126
Deriziotis, P., André, R., Smith, D. M., Goold, R., Kinghorn, K. J., Kristiansen, M., Nathan, J. A., Rosenzweig, R., Krutauz, D., Glickman, M. H., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.224 · Cited by 125
Anti-tumor activity of non-steroidal anti-inflammatory drugs: Cyclooxygenase-independent targets
Liggett, J. L., Zhang, X., Eling, T. E., & Baek, S. J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.021 · Cited by 124
NF‐κB as the mediator of metformin's effect on ageing and ageing‐related diseases
Kanigur Sultuybek, G., Soydas, T., & Yenmis, G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13073 · Cited by 119
Jeong, J. B., Choi, J., Lou, Z., Jiang, X., & Lee, S. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.04.006 · Cited by 121
Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia
Katsha, A. M., Soutto, M., Sehdev, V., Peng, D., Washington, M. K., Piazuelo, M. B., Tantawy, M. N., Manning, H. C., Lu, P., Shyr, Y., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.050 · Cited by 116
Salminen, A., Ojala, J. O., Huuskonen, J., Kauppinen, A., Suuronen, T., & Kaarniranta, K. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7461-3 · Cited by 120
The role of microRNAs in metastasis and epithelial-mesenchymal transition
Bracken, C. P., Gregory, P. A., Khew‐Goodall, Y., & Goodall, G. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8750-1 · Cited by 119
Srikanth, K., Kwon, A., Lee, E., & Chung, H. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0739-8 · Cited by 115
Liao, D. J., Thakur, A. B., Wu, J., Biliran, H., & Sarkar, F. H. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i2.10 · Cited by 116
A multi-targeted approach to suppress tumor-promoting inflammation
Samadi, A. K., Bilsland, A. E., Georgakilas, A. G., Amedei, A., Amin, A., Bishayee, A., Azmi, A. S., Lokeshwar, B. L., Grue, B., Panis, C., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.006 · Cited by 118
Pro-apoptotic role of NF-κB: Implications for cancer therapy
Radhakrishnan, S. K., & Kamalakaran, S. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.001 · Cited by 115
Maternal Diabetes Modulates Renal Morphogenesis in Offspring
Tran, S., Chen, Y., Chénier, I., Chan, J. S. D., Quaggin, S. E., Accent]bert, M.-J. A. A. H. A., Ingelfinger, J. R., & Zhang, S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007080864 · Cited by 109
Keeping up NF-κB appearances: Epigenetic control of immunity or inflammation-triggered epigenetics
Berghe, W. V., Ndlovu, ’. N., Hoya-Arias, R., Dijsselbloem, N., Gerlo, S., & Haegeman, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.012 · Cited by 108
Melatonin, clock genes and mitochondria in sepsis
Acuña-Castroviejo, D., Rahim, I., Acuña‐Fernández, C., Fernández‐Ortiz, M., Marín, J. S., Sayed, R. K. A., Díaz-Casado, M. E., Rusanova, I., López, L. C., & Escames, G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2610-1 · Cited by 115
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression
Wang, W., Mani, A. M., & Wu, Z. (2017) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.03 · Cited by 112
Gjevestad, G. O., Holven, K. B., & Ulven, S. M. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0463-4 · Cited by 102
Lim, S.-M., Jeong, J.-J., Kang, G., Kim, K., Choi, H.-S., & Kim, D. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.016 · Cited by 102
miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1
Arora, H., Qureshi, R., Jin, S., Park, A.-K., & Park, W. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.5.031 · Cited by 100
The IκB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy
Gammeren, D. V., Damrauer, J. S., Jackman, R. W., & Kandarian, S. C. (2008) · The FASEB Journal · doi:10.1096/fj.08-114249 · Cited by 102
Ge, H., Tang, H., Liang, Y., Wu, J., Yang, Q., Zeng, L., & Ma, Z.-F. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s133069 · Cited by 100
NF-κB: Governing Macrophages in Cancer
Cornice, J., Verzella, D., Arboretto, P., Vecchiotti, D., Capece, D., Zazzeroni, F., & Franzoso, G. (2024) · Genes · doi:10.3390/genes15020197 · Cited by 108
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
Li, C., Chen, S., Yue, P., Deng, X., Lonial, S., Khuri, F. R., & Sun, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072694 · Cited by 99
Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation.Preprint
Puto, L. A., & Reed, J. C. (2008) · Genes & Development · doi:10.1101/gad.1632208 · Cited by 114
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsPreprint
Hua, J., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., et al. (2011) · Genes & Development · doi:10.1101/gad.17620611 · Cited by 102
Liu, D., Wang, Y., Jia, Z., Wang, L., Wang, J., Yang, D., Song, J.-Q., Wang, S., & Fan, Z. (2015) · Stem Cells · doi:10.1002/stem.2018 · Cited by 99
Jang, S., Jeong, J.-J., Hyam, S. R., Han, M. J., & Kim, D. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501487v · Cited by 97
Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome
Wu, M., Bian, Q., Liu, Y., Fernandes, A. F., Taylor, A., Pereira, P., & Shang, F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.021 · Cited by 99
Wang, C., Yan, Y., Gao, S., Chen, J., Yu, J., Zhang, H., Li, M., Zhan, X., & Li, W. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.013 · Cited by 95
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer
Chen, W., Qin, Y., Wang, D., Zhou, L., Liu, Y., Chen, S., Yin, L., Xiao, Y., Yao, X.-H., Yang, X., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005869 · Cited by 94
Adenosine A2B Receptor: From Cell Biology to Human Diseases
Sun, Y., & Huang, P. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00037 · Cited by 91
RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair
Wang, J., Jacob, N. K., Ladner, K. J., Beg, A. A., Perko, J. D., Tanner, S. M., Liyanarachchi, S., Fishel, R. A., & Guttridge, D. C. (2009) · EMBO Reports · doi:10.1038/embor.2009.197 · Cited by 91
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers
Cojocneanu, R., Braicu, C., Ráduly, L., Dragoş, N., Dumitrascu, D. L., Berindan‐Neagoe, I., Zănoagă, O., & Monroig-Bosque, P. D. C. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s83597 · Cited by 89
IκBNS Protein Mediates Regulatory T Cell Development via Induction of the Foxp3 Transcription Factor
Schuster, M., Glauben, R., Plaza‐Sirvent, C., Schreiber, L., Annemann, M., Floess, S., Kühl, A. A., Clayton, L. K., Sparwasser, T. D., Schulze‐Osthoff, K., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.023 · Cited by 86
Apoptosis in normal and cancer stem cells
Iannolo, G., Conticello, C., Memeo, L., & Maria, R. D. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.09.004 · Cited by 88
Metadata
- Authors
- Perkins, N. D., & Gilmore, T. D.
- Affiliations
- University of Dundee (GB)
- Boston University (US)
- Corresponding author
- Perkins, N D
- Venue
- Cell Death & Differentiation
- Published
- 2006-01-13
- Volume
- 13
- Issue
- 5
- Pages
- 759-772
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1533671266
- Cited by
- 489
- References
- 103
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 22 · 2023: 21 · 2022: 15 · 2021: 21 · 2020: 23 · 2019: 13 · 2018: 19 · 2017: 24 · 2016: 19 · 2015: 30 · 2014: 38 · 2013: 22 · 2012: 26
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust
- Cancer Research UK
- Royal Society
- National Institutes of Health
- National Cancer Institute (CA 47763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- NF-κB, transcription factors, tumor suppression, gene expression regulation, NF-κB subunits
- MeSH terms
- Carcinogens, Humans, Models, Biological, Neoplasms, Signal Transduction, NF-kappa B, Tumor Suppressor Proteins, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review